Multi-Site Observational Study to Assess Biomarkers for Susceptibility or Resilience to Chronic Pain: The Acute to Chronic Pain Signatures (A2CPS) Study Protocol
Journal Article
·
· Frontiers in Medicine
more »
- Univ. of Iowa, Iowa City, IA (United States)
- St. Ambrose Univ., Davenport, IA (United States)
- Rush Univ. Medical Center, Chicago, IL (United States)
- Univ. of Illinois, Chicago, IL (United States)
- NorthShore University HealthSystem, Skokie, IL (United States)
- Univ. of Chicago, IL (United States)
- Univ. of Michigan, Ann Arbor, MI (United States)
- Univ. of California, San Diego, CA (United States)
- Wake Forest Univ., Winston-Salem, NC (United States)
- Univ. of California, Davis, CA (United States)
- Pacific Northwest National Lab. (PNNL), Richland, WA (United States)
- Univ. of Pittsburgh, PA (United States)
- Johns Hopkins Univ., Baltimore, MD (United States)
- Univ. of Texas, Austin, TX (United States)
- Dartmouth College, Hanover, NH (United States)
- National Institutes of Health (NIH), Bethesda, MD (United States)
Chronic pain has become a global health problem contributing to years lived with disability and reduced quality of life. Advances in the clinical management of chronic pain have been limited due to incomplete understanding of the multiple risk factors and molecular mechanisms that contribute to the development of chronic pain. The Acute to Chronic Pain Signatures (A2CPS) Program aims to characterize the predictive nature of biomarkers (brain imaging, high-throughput molecular screening techniques, or “omics,” quantitative sensory testing, patient-reported outcome assessments and functional assessments) to identify individuals who will develop chronic pain following surgical intervention. The A2CPS is a multisite observational study investigating biomarkers and collective biosignatures (a combination of several individual biomarkers) that predict susceptibility or resilience to the development of chronic pain following knee arthroplasty and thoracic surgery. This manuscript provides an overview of data collection methods and procedures designed to standardize data collection across multiple clinical sites and institutions. Pain-related biomarkers are evaluated before surgery and up to 3 months after surgery for use as predictors of patient reported outcomes 6 months after surgery. The dataset from this prospective observational study will be available for researchers internal and external to the A2CPS Consortium to advance understanding of the transition from acute to chronic postsurgical pain.
- Research Organization:
- Pacific Northwest National Laboratory (PNNL), Richland, WA (United States)
- Sponsoring Organization:
- National Institutes of Health (NIH); USDOE
- Contributing Organization:
- The Acute to Chronic Pain Signatures Consortium
- Grant/Contract Number:
- AC05-76RL01830
- OSTI ID:
- 1882664
- Report Number(s):
- PNNL-SA-169089
- Journal Information:
- Frontiers in Medicine, Journal Name: Frontiers in Medicine Vol. 9; ISSN 2296-858X
- Publisher:
- Frontiers Media S.A.Copyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Predicting chronic postsurgical pain: current evidence and a novel program to develop predictive biomarker signatures
Clinical Outcomes of Transcatheter Arterial Embolisation for Chronic Knee Pain: Mild-to-Moderate Versus Severe Knee Osteoarthritis
The value of indium 111 leukocyte scanning in the evaluation of painful or infected total knee arthroplasties
Journal Article
·
Wed Jun 14 20:00:00 EDT 2023
· Pain
·
OSTI ID:2202571
Clinical Outcomes of Transcatheter Arterial Embolisation for Chronic Knee Pain: Mild-to-Moderate Versus Severe Knee Osteoarthritis
Journal Article
·
Thu Nov 14 23:00:00 EST 2019
· Cardiovascular and Interventional Radiology
·
OSTI ID:22970452
The value of indium 111 leukocyte scanning in the evaluation of painful or infected total knee arthroplasties
Journal Article
·
Mon Oct 01 00:00:00 EDT 1990
· Clinical Orthopaedics and Related Research; (USA)
·
OSTI ID:6142410